Shiel K Patel1, Patrick J Hanly2,3,4, Eric E Smith1,5,6,3,7, Wesley Chan1, Shelagh B Coutts1,5,6,3,7. 1. Clinical Neurosciences, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada. 2. Medicine, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada. 3. Hotchkiss Brain Institute, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada. 4. Sleep Centre, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada. 5. Radiology, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada. 6. Community Health Sciences, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada. 7. Seaman Family MR Centre, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
Abstract
STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is a risk factor for stroke, which is modulated by accompanying nocturnal hypoxemia. White matter hyperintensities (WMH) share many of the same risk factors as stroke. The purpose of this study was to investigate whether OSA and nocturnal hypoxemia are associated with white matter disease in patients with minor stroke and transient ischemic attack. METHODS: Patients with minor stroke or TIA were recruited. Level 3 diagnostic sleep testing was used to diagnose OSA and quantify nocturnal hypoxemia. Significant OSA was defined as respiratory disturbance index ≥ 15, and nocturnal hypoxemia was defined as oxyhemoglobin saturation < 90% for ≥ 12% of total monitoring time. WMH were assessed and quantified on FLAIR MRI. The volume of WMH was compared between those with and without significant OSA and between those with and without nocturnal hypoxemia. RESULTS: One hundred nine patients were included. Thirty-four (31%) had OSA and 37 (34%) had nocturnal hypoxemia. Total WMH volume was significantly greater in the OSA than in the non-OSA groups (p = 0.04). WMH volume was also significantly higher in the hypoxic than the non-hypoxic groups (p = 0.001). Mutivariable analysis with adjustment for age, hypertension, and diabetes showed that nocturnal hypoxemia was independently associated with WMH volume (p = 0.03) but OSA was not (p = 0.29). CONCLUSIONS: We conclude that nocturnal hypoxemia, predominantly related to OSA, is independently associated with WMH in patients who present with minor ischemic stroke and TIA and may contribute to its pathogenesis.
STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is a risk factor for stroke, which is modulated by accompanying nocturnal hypoxemia. White matter hyperintensities (WMH) share many of the same risk factors as stroke. The purpose of this study was to investigate whether OSA and nocturnal hypoxemia are associated with white matter disease in patients with minor stroke and transient ischemic attack. METHODS:Patients with minor stroke or TIA were recruited. Level 3 diagnostic sleep testing was used to diagnose OSA and quantify nocturnal hypoxemia. Significant OSA was defined as respiratory disturbance index ≥ 15, and nocturnal hypoxemia was defined as oxyhemoglobin saturation < 90% for ≥ 12% of total monitoring time. WMH were assessed and quantified on FLAIR MRI. The volume of WMH was compared between those with and without significant OSA and between those with and without nocturnal hypoxemia. RESULTS: One hundred nine patients were included. Thirty-four (31%) had OSA and 37 (34%) had nocturnal hypoxemia. Total WMH volume was significantly greater in the OSA than in the non-OSA groups (p = 0.04). WMH volume was also significantly higher in the hypoxic than the non-hypoxic groups (p = 0.001). Mutivariable analysis with adjustment for age, hypertension, and diabetes showed that nocturnal hypoxemia was independently associated with WMH volume (p = 0.03) but OSA was not (p = 0.29). CONCLUSIONS: We conclude that nocturnal hypoxemia, predominantly related to OSA, is independently associated with WMH in patients who present with minor ischemic stroke and TIA and may contribute to its pathogenesis.
Authors: F J Nieto; T B Young; B K Lind; E Shahar; J M Samet; S Redline; R B D'Agostino; A B Newman; M D Lebowitz; T G Pickering Journal: JAMA Date: 2000-04-12 Impact factor: 56.272
Authors: E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet Journal: Am J Respir Crit Care Med Date: 2001-01 Impact factor: 21.405
Authors: Sarah E Vermeer; Monika Hollander; Ewoud J van Dijk; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: Stroke Date: 2003-04-10 Impact factor: 7.914
Authors: Jingzhong Ding; F Javier Nieto; Norman J Beauchamp; Tamara B Harris; John A Robbins; Jacqueline B Hetmanski; Linda P Fried; Susan Redline Journal: Sleep Date: 2004-05-01 Impact factor: 5.849
Authors: Noah C Schammel; Trevor VandeWater; Stella Self; Christopher Wilson; Christine M G Schammel; Ronald Cowley; Dominic B Gault; Lee A Madeline Journal: Brain Imaging Behav Date: 2022-02-26 Impact factor: 3.224
Authors: Helena U Zacharias; Antoine Weihs; Mohamad Habes; Katharina Wittfeld; Stefan Frenzel; Tanweer Rashid; Beate Stubbe; Anne Obst; András Szentkirályi; Robin Bülow; Klaus Berger; Ingo Fietze; Thomas Penzel; Norbert Hosten; Ralf Ewert; Henry Völzke; Hans J Grabe Journal: JAMA Netw Open Date: 2021-10-01